AGL 40.21 Increased By ▲ 0.18 (0.45%)
AIRLINK 127.64 Decreased By ▼ -0.06 (-0.05%)
BOP 6.67 Increased By ▲ 0.06 (0.91%)
CNERGY 4.45 Decreased By ▼ -0.15 (-3.26%)
DCL 8.73 Decreased By ▼ -0.06 (-0.68%)
DFML 41.16 Decreased By ▼ -0.42 (-1.01%)
DGKC 86.11 Increased By ▲ 0.32 (0.37%)
FCCL 32.56 Increased By ▲ 0.07 (0.22%)
FFBL 64.38 Increased By ▲ 0.35 (0.55%)
FFL 11.61 Increased By ▲ 1.06 (10.05%)
HUBC 112.46 Increased By ▲ 1.69 (1.53%)
HUMNL 14.81 Decreased By ▼ -0.26 (-1.73%)
KEL 5.04 Increased By ▲ 0.16 (3.28%)
KOSM 7.36 Decreased By ▼ -0.09 (-1.21%)
MLCF 40.33 Decreased By ▼ -0.19 (-0.47%)
NBP 61.08 Increased By ▲ 0.03 (0.05%)
OGDC 194.18 Decreased By ▼ -0.69 (-0.35%)
PAEL 26.91 Decreased By ▼ -0.60 (-2.18%)
PIBTL 7.28 Decreased By ▼ -0.53 (-6.79%)
PPL 152.68 Increased By ▲ 0.15 (0.1%)
PRL 26.22 Decreased By ▼ -0.36 (-1.35%)
PTC 16.14 Decreased By ▼ -0.12 (-0.74%)
SEARL 85.70 Increased By ▲ 1.56 (1.85%)
TELE 7.67 Decreased By ▼ -0.29 (-3.64%)
TOMCL 36.47 Decreased By ▼ -0.13 (-0.36%)
TPLP 8.79 Increased By ▲ 0.13 (1.5%)
TREET 16.84 Decreased By ▼ -0.82 (-4.64%)
TRG 62.74 Increased By ▲ 4.12 (7.03%)
UNITY 28.20 Increased By ▲ 1.34 (4.99%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 10,086 Increased By 85.5 (0.85%)
BR30 31,170 Increased By 168.1 (0.54%)
KSE100 94,764 Increased By 571.8 (0.61%)
KSE30 29,410 Increased By 209 (0.72%)

Britain on Tuesday granted the scientist, who created Dolly the sheep, the world's first cloned mammal, a licence to clone human embryos "for medical research", triggering an outcry among opposition groups. Ian Wilmut, from the Roslin Institute in Edinburgh, dismissing fears that his work would lead to reproductive cloning, said the licence would allow him and his team to study the fatal 'motor neuron disease' (MND).
"Our aim will be to generate stem cells, purely for research purposes," said Wilmut, who will also work with researchers from King's College, University of London.
It is only the second time that Britain's fertility body, the 'Human Fertilisation and Embryology Authority', has issued a licence for therapeutic cloning research, which has been legal in the country since 2001.
"Human beings have been changing the world around them for a very long time, in general to good effect," Wilmut told a news conference in Edinburgh.
"I think that the majority of people support this type of research and hope it will be successful in helping to bring useful treatment for diseases like motor neuron disease," he said. Wilmut's team plans to extract stem cells from patients with MND and implant them in unfertilised eggs to create cloned embryos.
They will then harvest stem cells from the embryos to grow motor neurones --the long nerves which transmit electrical messages from the brain and spinal cord to the muscles. The technique will not be used to correct the disease, which is caused by the death of motor neurones and affects about 5,000 people in Britain, but the study of the cells could help to develop future treatments.
Wilmut shot to fame in July 1996 when he created Dolly the sheep, the first mammal ever to be cloned from an adult cell. Dolly was put down two years ago this month after she developed a lung disease.
Critics of embryo cloning fear that Britain is one step closer to authorising the creation of human clones, but Wilmut dismissed such fears. "This is not reproductive cloning in any way. The eggs we use will not be allowed to grow beyond 14 days," he said.

Copyright Agence France-Presse, 2005

Comments

Comments are closed.